Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aptose Biosciences Inc T.APS

Alternate Symbol(s):  APTO

Healthcare Biotechnology
Aptose Biosciences Inc. is a clinical-stage biotechnology company. The Company is engaged in the development and commercialization of precision medicines addressing unmet clinical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:APS)

Aptose Reports Results for the Fourth Quarter and Full Year 2023

GlobeNewswire March 26, 2024

Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024

GlobeNewswire March 18, 2024

Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option

GlobeNewswire January 31, 2024

Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

GlobeNewswire January 26, 2024

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting

GlobeNewswire December 9, 2023

Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role

GlobeNewswire November 30, 2023

Aptose Reports Results for the Third Quarter 2023

GlobeNewswire November 9, 2023

Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting

GlobeNewswire November 2, 2023

Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib

GlobeNewswire October 30, 2023
View More News ››

Opinion & Analysis (TSX:APS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:APS)

Monday is gonna go up

The pumpers are on
Nibinator - October 28, 2023

APS - A NASTY STOCK

The latest surge in the share price and recent pullback is no doubt a pump and dump.  However, given that the company has money on...
modulex - November 11, 2022

RE:Wow, what happened? Looked like the news was good?

in hindsight ---- we at the investment club are hoping that its not a P &D
CamelHurder - October 31, 2022

Did anyone get the ALERT

Chart says the only way now is UP   https://youtu.be/XY49AWnFGDw
CamelHurder - October 11, 2022

RE:RE:RE:RE:Wow, what happened? Looked like the news was good?

Yes glory I remember you......This is one of the best  scheme like situations I have ever encountered...I remember the Dr wright...
ardbegoil - June 4, 2022

RE:RE:RE:Wow, what happened? Looked like the news was good?

A 20 year scam, nothing more? Had it for years but not the past few (know better).
glory7 - December 14, 2021
View more Bullboard ››

NurExone Biologic Inc

NurExone Biologic Inc

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ...
View More »